UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.29+0.28 (+4.66%)
As of 11:37AM EST. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-8,665
-172,415
-183,524
-176,145
-132,617
Depreciation & amortisation
4,183
4,093
4,067
1,391
293.886
Stock-based compensation
13,933
18,125
10,679
10,694
8,662
Change in working capital
-3,548
-520
-3,316
-14,000
16,364
Accounts receivable
4,277
-4,327
-8,200
-13,640
-6,951
Inventory
588
-711
-3,337
-8,593
-1,782
Accounts payable
-5,460
-750
1,887
-3,563
18,646
Other working capital
-105,240
-144,916
-161,068
-189,590
-128,134
Other non-cash items
25,158
7,491
11,142
1,919
269.859
Net cash provided by operating activities
-103,408
-142,693
-159,470
-165,698
-106,812
Cash flows from investing activities
Investments in property, plant and equipment
-1,832
-2,223
-1,598
-23,892
-21,322
Other investing activities
-20.42
-
-
-20.42
-175.41
Net cash used for investing activities
140,802
-2,223
-1,598
-23,913
-21,498
Cash flows from financing activities
Debt repayment
-125,000
-50,000
0
-81,661
-
Common stock issued
3,568
184,115
31,703
77,031
89,908
Other financing activities
1,022
-5,118
-1,250
-6,652
-3,787
Net cash used provided by (used for) financing activities
-103,905
129,552
80,724
188,827
162,787
Net change in cash
-66,511
-15,364
-80,344
-783.364
34,477
Cash at beginning of period
104,841
80,486
160,830
161,613
127,136
Cash at end of period
38,330
65,122
80,486
160,830
161,613
Free cash flow
Operating cash flow
-103,408
-142,693
-159,470
-165,698
-106,812
Capital expenditure
-1,832
-2,223
-1,598
-23,892
-21,322
Free cash flow
-105,240
-144,916
-161,068
-189,590
-128,134